D

Journey Medical Corp

D
DERM
USD
-0.02
(-0.3854%)
Market Closed
759.00
Volume
-0.905
EPS
-
Div Yield
39.769
P/E
107,159,815.29
Market Cap
Today
-0.3854%
1 Week
2.579%
1 Month
12.882%
6 Months
35.767%
12 Months
108.468%
Year To Date
-9.773%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ACAD
0.11
(0.6736%)
USD
A
AXSM
2.77
(3.0257%)
USD
I
INCY
1.67
(2.5625%)
USD
M
MCRB
-0.015
(-1.4286%)
USD
N
NBIX
0.63
(0.5258%)
USD
N
NKTR
0.005
(0.3953%)
USD
S
SRPT
1.96
(1.5667%)
USD
T
TGTX
0.05
(0.1981%)
USD
X
XNCR
0.36
(1.7266%)
USD

Title:
Journey Medical Corp

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Do you need help or have a question?
Contact Us